Rheumatoid disease and ischaemic heart disease: Insights from pathophysiology and vascular biology

International Journal of Cardiology

Volumn 105, Issue 1, 2005, Pages 1-10

  Bhatia, Gurbir S ^a   Sosin, Michael D ^a   Khattak, Fazal H ^b   Davis, Russell C ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Atherosclerosis; Ischaemic heart disease; Rheumatoid

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; HOMOCYSTEINE; MATRIX METALLOPROTEINASE;

ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL; CARDIOVASCULAR RISK; CELL FUNCTION; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LYMPHOCYTE; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SMOKING; SYSTEMIC DISEASE; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

CELL ADHESION MOLECULES; CYTOKINES; ENDOTHELIUM, VASCULAR; HOMOCYSTEINE; HUMANS; HYPERTENSION; MATRIX METALLOPROTEINASES; MOTOR ACTIVITY; MYOCARDIAL ISCHEMIA; RHEUMATIC HEART DISEASE; RISK FACTORS;

EID: 26044448555     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.12.064     Document Type: Review

References (104)

1. F. Wolfe, D.M. Mitchell, J.T. Sibley, J.F. Fries, D.A. Bloch, and C.A. Williams The mortality of rheumatoid arthritis Arthritis Rheum 37 1994 481 494
2. R. Myllykangas-Luosujarvi, K. Aho, H. Kautiainen, and H. Isomaki Cardiovascular mortality in women with rheumatoid arthritis J Rheumatol 22 1995 1065 1067
3. L. Sokoloff The heart in rheumatoid arthritis Am Heart J 45 1953 635 643
4. P. Prior, D.P.M. Symmons, D.L. Scott, R. Brown, and C.F. Hawkins Cause of death in rheumatoid arthritis Br J Rheumatol 1984 92 99
5. S. Wallberg-Jonsson, M.-L. Ohman, and S.R. Dahlqvist Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden J Rheumatol 24 1997 445 451
6. L. Bjornadal, E. Baecklund, L. Yin, F. Granath, L. Klareskog, and A. Ekbom Decreasing mortality in patients with rheumatoid arthritis: results from a large population-based cohort in Sweden, 1964-95 J Rheumatol 29 2002 906 912
7. F. Wolfe, B. Freundlich, and W.L. Strauss Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis J Rheumatol 30 2003 36 40
8. A. McEntegart, H.A. Capell, D. Creran, A. Rumley, M. Woodward, and G.D. Lowe Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis Rheumatology 40 2001 640 644
9. D.H. Solomon, E.W. Karlson, E.B. Rimm, C.C. Cannuscio, L.A. Mandl, and J.E. Manson Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 107 2003 1303 1307
10. I. Del Rincon, K. Williams, M.P. Stern, G.L. Freman, and A. Escalante High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 44 2001 2737 2745
11. M. Banks, A. Pace, and G. Kitas Acute coronary syndromes (ACS) present atypically and recur more frequently in rheumatoid arthritis than matched controls [abstract] Arthritis Rheum 44 2001 S53
12. T. Bonfiglio, and E.C. Atwater Heart disease in patients with seropositive rheumatoid arthritis Arch Intern Med 124 1969 714 719
13. W.B. Lebowitz The heart in rheumatoid arthritis (rheumatoid disease) Ann Intern Med 58 1963 102 123
14. A. Iglesias del Sol, M.L. Bots, D.E. Grobbee, A. Hofman, and J.C. Witteman Carotid intima-media thickness at different sites: relation to incident myocardial infarction (The Rotterdam Study) Eur Heart J 23 2002 934 940
15. Y. Kumeda, M. Inaba, H. Goto, M. Nagata, Y. Henmi, and Y. Furumitsu Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis Arthritis Rheum 46 2002 1489 1497
16. S. Wallberg Jonsson, C. Backman, O. Johnson, K. Karp, E. Lundstrom, and K.G. Sundqvist Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis J Rheumatol 28 2001 2597 2602
17. Y.B. Park, C.W. Ahn, H.K. Choi, S.H. Lee, B.H. In, and H.C. Lee Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound Arthritis Rheum 46 2002 1714 1719
18. M. Ho, T. Pullar, J.K. Alkaabi, R. Levison, and J.J. Belch Rheumatoid arthritis and macrovascular disease Rheumatol (Oxf Print) 42 2003 292 297
19. C. Gonzalez-Juanetey, J. Llorca, A. Testa, J. Revuelta, C. Garcia-Porma, and M.A. Gonzalez-Gay Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease Medicine (Baltimore) 82 2003 407 413
20. I. Del Rincon, K. Williams, M.P. Stem, G.L. Freeman, D.H. O'Leary, and A. Escalante Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis and healthy subjects Arthritis Rheum 48 2003 1833 1840
21. M. Nagata-Sakurai, M. Inaba, H. Goto, Y. Kumeda, Y. Furumitsu, and K. Inui Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis Arthritis Rheum 48 2003 3061 3067
22. T. Heitzer, K. Schlinzig, T. Krohn, T. Meinertz, and T. Munzel Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease Circulation 104 2001 2673 2678
23. F. Perticone, R. Ceravolo, A. Pujia, G. Ventura, S. Iacopino, and A. Scozzafava Prognostic significance of endothelial dysfunction in hypertensive patients Circulation 104 2001 191 196
24. K. Raza, J. Thambyrajah, J. Townend, A.R. Exley, C. Hortas, and A. Filer Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation 102 2000 1470 1472
25. P.A. Bacon, and J.N. Townwend Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis Arthritis Rheum 44 2001 2707 2710
26. R. Bergholm, M. Leirisalo-Repo, S. Vehkavaara, S. Makimattila, M.R. Takinen, and H. Yki-Jarvinen Impaired responsiveness to newly-diagnosed patients with rheumatoid arthritis Arterioscler Thromb Vasc Biol 22 2002 1637 1641
27. H. Yki-Jarvinen, R. Bergholm, and M. Leirisalo-Repo Increased inflammatory activity parallels increased basal nitric oxide production and blunted response in vivo in rheumatoid arthritis Ann Rheum Dis 62 2003 630 644
28. S. Hansel, G. Lassig, F. Pistrosch, and J. Passauer Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity Atherosclerosis 170 2003 177 180
29. D. Hurlimann, A. Forster, G. Noll, F. Enseleit, R. Chenevard, and O. Distler Anti tumour necrosis factor alpha improves endothelial function in patients with rheumatoid arthritis Circulation 106 2002 2184 2187
30. C. Gonzalez-Juanatey, A. Testa, A. Garcia Castelo, C. Garcia Purrua, J. Llorca, and J. Vidan HLA DRB1 status affects endothelial dysfunction in treated patients with rheumatoid arthritis Am J Med 114 2003 647 652
31. S. Van Doornum, G. McColl, A. Jenkins, D.J. Green, and I.P. Wicks Screening for atherosclerosis in patients with rheumatoid arthritis: a comparison of two in vivo tests of vascular function Arthritis Rheum 48 2003 72 80
32. E. Grey, C. Bratteli, S.P. Glasser, C. Alinder, S.M. Finkelstein, and B.R. Lindgren Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events Am J Hypertens 16 2003 265 269
33. M. Wong, L. Toh, A. Wilson, K. Rowley, C. Karschimkus, and D. Prior Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation Arthritis Rheum 48 2003 81 89
34. R. Klocke, J.R. Cockcroft, G.J. Taylr, I.R. Hall, and D.R. Blake Arterial stiffness and central blood pressure, as determined by pulse wave analysis in rheumatoid arthritis patients Ann Rheum Dis 62 2003 414 418
35. D.C. Felmeden, C.G. Spencer, N.A. Chung, F.M. Belgore, A.D. Blann, and D.G. Beevers Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]) Am J Cardiol 92 2003 400 405
36. A.R. Folsom, K.K. Wu, W.D. Rosamond, Ar. Sharrett, and L.E. Chambles Prospective study of haemostatic factors and incidence of coronary heart disase: the Atherosclerosis Risk in Communities (ARIC) study Circulation 96 1999 1102 1108
37. C. Bickel, H.J. Rupprecht, S. Blankenberg, C. Espiniola-Klein, A. Schlitt, and G. Rippin Relation of markers of inflammation and statin therapy to long-term mortality in patients with angiographically-proven coronary artery disease Am J Cardiol 89 2002 901 908
38. A.D. Blann, J. Hopkins, J. Winkles, and A.C. Wainwrigh Plasma and serum von Willebrand factor antigen concentrations in connective tissue disorders Ann Clin Biochem 29 1992 67 71
39. A.D. Blann, A. Herrick, and M.I. Jayson Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis Br J Rheumatol 34 1995 814 819
40. S. Wallberg-Jonsson, J.T. Cvetkovi, K.-G. Sundqvist, A.K. Lefvert, and S. Rantapaa-Dahlqvist Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis J Rheumatol 29 2002 875 882
41. S. Wallberg-Jonsson, M. Cederfelt, and S. Rantapaa-Dahlqvist Haemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year follow-up study J Rheumatol 27 2002 71 75
42. R. Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 126
43. T.H. Kuller, R.P. Tracy, J. Shaten, and E.N. Meilahn Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study Am J Epidemiol 14 1996 537 547
44. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular events in apparently healthy men N Engl J Med 336 1997 973 979
45. R.P. Tracy, R.N. Lemaitre, B.M. Psaty, D.G. Ives, R.W. Evans, and M. Cushman Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the cardiovascular health study and the rural health promotion project Arterioscler Thromb Vasc Biol 17 1997 1121 1127
46. P.M. Ridker, J.E. Buring, J. Shih, M. Matias, and C.H. Hennekens Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 1998 731 733
47. W. Koenig, M. Sund, M. Frolich, H.G. Fischer, H. Lowel, and A. Doring C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA Augsburg cohort study Circulation 99 1999 237 242
48. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
49. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-Reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
50. P.M. Sweetnam, H.D. Thomas, and J.W. Yarnell Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease Eur Heart J 17 1996 1814 1820
51. J. Ma, C.H. Hennekens, P.M. Ridker, and M.J. Stampfer A prospective study of fibrinogen and risk of myocardial infarction in the Physician's Health Study J Am Coll Cardiol 33 1999 1347 1352
52. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct inflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
53. K.J. Woollard, Dc. Phillips, and H.R. Griffiths Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells Clin Exp Immunol 130 2002 256 262
54. T.P. Zwaka, V. Hombach, and J. Torzewski C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis Circulation 103 2001 1194 1197
55. E.J. Kroot, M.A. van Leeuwen, M.H. van Rijswijk, M.L. Prevoo, M.A. Van't Hof, and L.B. van De Putte No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset Ann Rheum Dis 59 2000 954 958
56. H.K. Choi, M.A. Herman, J.D. Seeger, J.M. Robins, and F. Wolfe Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 2002 1173 1177
57. D.W. McCarey, I.B. McInnes, R. Madhok, R. Hampson, O. Scherbakov, and I. Ford Trial of atorvastatin in rheumatoid arthritis (TARA): double blind, randomised placebo-controlled trial Lancet 363 2004 2015 2021
58. P.M. Ridker, N. Rifai, M.J. Stampfer, and C.H. Hennekens Plasma concentration of interleukin-6 and the risk of future myocardial infarction among healthy men Circulation 101 2000 1767 7172
59. P.M. Ridker, N. Rifai, M. Pfeffer, F. Sacks, S. Lepage, and E. Braunwald Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction Circulation 101 2000 2149 2153
60. N. Varo, J.A. de Lemos, P. Libby, D.A. Morrow, S.A. Murphy, and R. Nuzzo Soluble CD40L: risk prediction after acute coronary syndromes Circulation 10 2003 1049 1052
61. U. Schonbeck, N. Varo, P. Libby, J. Buring, and P.M. Ridker Soluble CD40L and cardiovascular risk in women Circulation 104 2001 2266 2268
62. J.V. Castell, M.J. Gomez-Luchon, M. Davis, R. Fabra, R. Trullenque, and P.C. Heinrich Acute phase response of human hepatocytes: regulation of acute phase protein synthesis by interleukin 6 Hepatology 12 1990 1179 1186
63. E.H. Choy, and G.S. Panayi Cytokine pathways and joint inflammation in rheumatoid arthritis N Engl J Med 344 2001 907 916
64. AD. Blann, C. Steele, and C.N. McCollum The influence of smoking on soluble adhesion molecules and endothelial cell markers Thromb Res 85 1997 433 438
65. A. Hackman, Y. Abe, W. Insull Jr, H. Pownall, L. Smith, and K. Dunn Levels of soluble cell adhesion molecules in patients with dyslipidaemia Circulation 93 1996 1334 1348
66. S.J. Hwang, C.M. Ballantyne, A.R. Sharrett, L.C. Smith, and C.E. Davis Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities study (ARIC) Circulation 96 1997 4219 4225
67. P.M. Ridker, C.H. Hennekens, B. Roitman-Johnson, M.J. Stampfer, and J. Allen Plasma concentration of soluble intercellular adhesion molecule-1 and risks of future MI in apparently healthy men Lancet 351 1998 88 92
68. S. Blankenberg, H.J. Rupprecht, C. Bickel, D. Peetz, G. Hafner, and L. Tiret Circulating cell adhesion molecules and death in patients with coronary artery disease Circulation 104 2001 1336 1342
69. D.M. Lee, and M.E. Weinblatt Rheumatoid arthritis Lancet 358 2001 903 911
70. E.M. Paleolog Angiogenesis in rheumatoid arthritis Arthritis Res 4 suppl 3 2002 S81 S90
71. K.S. Moulton, K. Vakili, D. Zurakowski, M. Soliman, C. Butterfield, and E. Sylvin Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis Proc Natl Acad Sci U S A 100 2003 4736 4741
72. A.D. Blann, F.M. Belgore, C.N. McCollum, S. Silverman, P.L. Lip, and G.Y.H. Lip VEGF and its receptor Flt1 in the plasma of patients with coronary and peripheral atherosclerosis and type II diabetes Clin Sci 102 2002 187 194
73. N. Stratford, K. Britten, and P. Galagher Inflammatory infiltrates in human coronary atherosclerosis Atherosclerosis 59 1986 271 276
74. D. Liuzzo, S.L. Kopecky, R.L. Frye, W.M. O'Fallon, A. Maseri, and J.J. Goronzy Perturbation of the T cell repertoire in patients with unstable angina Circulation 100 1999 2135 2139
75. M.-C. Aubry, D.L. Riehle, W.D. Edwards, H. Maradit-Kremers, V.L. Roger, and T.J. Sebo B-lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations Cardiovasc Pathol 13 2004 233 236
76. Z.S. Galis, G.K. Sukhova, M.W. Lark, and P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
77. M.J. Green, A.K.S. Gough, J. Devlin, J. Smith, P. Astin, and D. Taylor Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis Rheumatology 42 2003 83 88
78. C.S. Lau, M. McLaren, J. Hanslip, M. Kerr, and J.J.F. Belch Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis Ann Rheum Dis 5 1993 643 649
79. M. Heliovaara, K. Aho, A. Aromaa, P. Knekt, and A. Reunanen Smoking and risk of rheumatoid arthritis J Rheumatol 20 1993 1830 1835
80. C. Turesson, W.M. O'Fallon, C.S. Crowson, S.E. Gabriel, and E.L. Matteson Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years Ann Rheum Dis 62 2003 722 727
81. K.L. Svenson, H. Lithell, R. Hallgren, I. Selinus, and B. Vessby Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides: I. Relativity to inflammatory activity Arch Intern Med 147 1987 1912 1916
82. S. Rantapaa-Dahlqvist, S. Wallberg-Jonsson, and G. Dahlen Lipoprotein (a), lipids and lipoproteins in patients with rheumatoid arthritis Ann Rheum Dis 50 1991 366 368
83. Y. Asanuma, S. Kawai, H. Aoshima, J. Kaburaki, and Y. Mizushima Serum lipoprotein (a) and apolipoprotein (a) phenotypes in patients with rheumatoid arthritis Arthritis Rheum 42 1999 443 447
84. 2 to this atherogenic profile Arthritis Rheum 44 2001 2761 2767
85. W.P. Castelli, R.J. Garrison, P.W.F. Wilson, R.D. Abbott, S. Kalousdian, and W.B. Kannel Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study JAMA 256 1986 2835 2838
86. Y.B. Park, H.K. Choi, M.Y. Kim, W.K. Lee, J. Song, and D.K. Lim Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study Am J Med 113 2002 188 193
87. M. Boers, M.T. Nurmohamed, C.J. Doelman, L.R. Lard, A.C. Verhoeven, and A.E. Voskuyl Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis Ann Rheum Dis 62 2003 842 845
88. P.H. Dessein, A.E. Stanwix, and B.I. Joffe Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis Arthritis Res 4 2002 R5
89. J.S. Yudkin, C.D.A. Stehouwer, J.J. Emeis, and S.W. Coppack C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role of cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19 1999 972 978
90. A. Festa, R. D'Agostino, G. Howard, L. Mykkanen, R.P. Tracy, and S.M. Haffner Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 2000 42 47
91. P. Arner The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones Trends Endocrinol Metab 14 2003 137 145
92. A.R. Sharrett, C.M. Ballantyne, S.A. Coady, G. Heiss, P.D. Sorlie, and D. Catellier Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins A, I and B, and HDL density subfractions: the ARIC study Circulation 104 2001 1108 1113
93. H.D. Sesso, R.S. Paffenbarger Jr, and I.M. Lee Physical activity and coronary heart disease in men: the Harvard Alumni Health study Circulation 102 2000 975 980
94. I.M. Lee, H.D. Sesso, Y. Oguma, and R.S. Paffenbarger Jr. Relative intensity of physical activity and risk of coronary heart disease Circulation 107 2003 1110 1116
95. A. Wagner, C. Simon, A. Evans, J. Ferrieres, M. Montaye, and P. Ducimetiere Physical activity and coronary event incidence in Northern Ireland and France. The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Circulation 105 2002 2247 2252
96. S.G. Wannamethee, G.D. Lowe, P.H. Whincup, A. Rumley, M. Walker, and L. Lennon Physical activity and haemostatic variables in elderly men Circulation 105 2002 1785 1790
97. S.H. Jackson, D.G. Beevers, and K. Myers Does long-term low-dose corticosteroid treatment cause hypertension? Clin Sci (London) 61 Suppl 7 1981 381 383
98. Johnson, AG, Nguyen, TV, Day, RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 121 289-300.
99. C. Bombadier VIGOR study group Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis N Engl J Med 343 2000 1520 1528
100. R. Roubenoff, P. Dellaripa, M.R. Nadeau, L.W. Abad, B.A. Muldoon, and J. Selhub Abnormal homocysteine metabolism in rheumatoid arthritis Arthritis Rheum 40 1997 718 722
101. A.E. Van Ede, R.F.J.M. Laan, H.J. Blom, G.H.J. Boers, C.J. Haagsma, and C.M.G. Thomas Homocysteine and folate status in metotrexate-treated patients in rheumatoid arthritis Rheumatology 41 2002 658 665
102. D.S. Wald, M. Law, and J.K. Morris Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis BMJ 325 2002 1202 1209
103. F.F. Willems, W.R.M. Aengevaeren, G.G.J. Boers, H.J. Blom, and F.W.A. Verheugt Coronary endothelial function in hyperhomocysteinaemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease J Am Coll Cardiol 40 2002 766 772
104. S.N. Doshi, I.F.W. McDowell, S.J. Moat, N. Payne, H.J. Durrant, and M.J. Lewis Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering Circulation 105 2002 22 26